Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Quick Order
GLP1R / GLP-1 Receptor
glucagon-like peptide 1 receptor
GLP1R, a Glucagon Receptor, has been suggested to affect the feelings of satiety or hunger, sensation of glucose levels, control of glucagon sensitivity of islets, and non insulin-dependent diabetes mellitus. Glucagon-like peptide 1 is an incretin hormone produced by enteroendocrine L-cells in the intestinal mucosa. The hormone is released in response to food intake and plays an important role in maintaining blood glucose homeostasis. Stimulation of the GLP-1R by endogenous hormone induces multiple complementary mechanisms, which together result in a lowering of circulating blood glucose levels. These mechanisms include receptor-mediated enhancement of glucose-induced insulin secretion from pancreatic -cells, inhibition of gastric emptying with a delay in the gastrointestinal resorption of nutrients, inhibition of glucagon secretion, and inhibition of food intake. Desensitization of GLP1R on pancreatic beta-cells is one of the causes of non insulin-dependent diabetes mellitus (NIDDM). GLP1R knockout mice are viable, develop normally, but exhibit increased levels of blood glucose following oral glucose challenge in association with diminished levels of circulating insulin. Recently it has been shown that overexpression of glucagon-like peptide-1 receptor improves learning in rats (During et al. 2003).
Beneficial effects of exendin-4 on experimental polyneuropathy in diabetic mice. Himeno T, Kamiya H, Naruse K, Harada N, Ozaki N, Seino Y, Shibata T, Kondo M, Kato J, Okawa T, Fukami A, Hamada Y, Inagaki N, Seino Y, Drucker DJ, Oiso Y, Nakamura J. Diabetes. 2011 60:2397-406. (IHC-Fr; Mouse)[Full Text Article]
[PubMed:21810596]
[PMC:PMC3161330]
Related Antibodies: LS-A1206, LS-A1205.
2
Pancreatic GLP-1 receptor activation is sufficient for incretin control of glucose metabolism in mice. Lamont BJ, Li Y, Kwan E, Brown TJ, Gaisano H, Drucker DJ. The Journal of clinical investigation. 2012 122:388-402. (IHC; Mouse)[Full Text Article]
[PubMed:22182839]
[PMC:PMC3248276]
Related Antibodies: LS-A1205.
3
GLP-1 Receptor Activation Indirectly Reduces Hepatic Lipid Accumulation But Does Not Attenuate Development of Atherosclerosis in Diabetic Male ApoE–/– Mice. Panjwani N, Mulvihill EE, Longuet C, Yusta B, Campbell JE, Brown TJ, Streutker C, Holland D, Cao X, Baggio LL, Drucker DJ. Endocrinology. 2013 154:127-39. (WB; Mouse, Hamster)[Full Text Article]
[PubMed:23183176]
Related Antibodies: LS-A1205.
Expression of the GLP-1 receptor in mouse, rat, and human pancreas. Tornehave D, Kristensen P, R[Character f8]mer J, Knudsen LB, Heller RS. The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society. 2013 Sep;56:841-51. [Full Text Article]
[PubMed:18541709]
[PMC:PMC2516959]
Related Antibodies: LS-A1206.
7
Ex vivo imaging of pancreatic beta cells using a radiolabeled GLP-1 receptor agonist. Connolly BM, Vanko A, McQuade P, Guenther I, Meng X, Rubins D, Waterhouse R, Hargreaves R, Sur C, Hostetler E. Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging. 2004 Feb;14:79-87. [Full Text Article]
[PubMed:21394533]
Related Antibodies: LS-A1206.
8
Exendin-4, a glucagon-like peptide-1 receptor agonist, attenuates neointimal hyperplasia after vascular injury. Hirata Y, Kurobe H, Nishio C, Tanaka K, Fukuda D, Uematsu E, Nishimoto S, Soeki T, Harada N, Sakaue H, Kitagawa T, Shimabukuro M, Nakaya Y, Sata M. European journal of pharmacology. 2013 Jan;699:106-11. [Full Text Article]
[PubMed:23220706]
Related Antibodies: LS-A1206.
9
Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4. Arakawa M, Mita T, Azuma K, Ebato C, Goto H, Nomiyama T, Fujitani Y, Hirose T, Kawamori R, Watada H. Diabetes. 2010 Apr;59:1030-7. [Full Text Article]
[PubMed:20068138]
[PMC:PMC2844811]
Related Antibodies: LS-A1205.
10
GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice. Noyan-Ashraf MH, Momen MA, Ban K, Sadi AM, Zhou YQ, Riazi AM, Baggio LL, Henkelman RM, Husain M, Drucker DJ. Diabetes. 2009 Apr;58:975-83. [Full Text Article]
[PubMed:19151200]
[PMC:PMC2661586]
Related Antibodies: LS-A1205.
11
IRS-2 deficiency in macrophages promotes their accumulation in the vascular wall. Mita T, Azuma K, Goto H, Jin WL, Arakawa M, Nomiyama T, Suzuki R, Kubota N, Tobe K, Kadowaki T, Fujitani Y, Hirose T, Kawamori R, Watada H. Biochemical and biophysical research communications. 2011 Dec;415:545-50. [Full Text Article]
[PubMed:22074825]
Related Antibodies: LS-A1205.
12
Glucagon-like peptide-1 modulates neurally evoked mucosal chloride secretion in guinea pig small intestine in vitro. Baldassano S, Wang GD, Mul[Character e8] F, Wood JD. American journal of physiology. Gastrointestinal and liver physiology. 2012 Feb;302:G352-8. [Full Text Article]
[PubMed:22075777]
[PMC:PMC3287398]
Related Antibodies: LS-A1205.
If you do not find the reagent or information you require, please contact Customer.Support@LSBio.com to inquire about additional products in development.
PLEASE NOTE
For RESEARCH USE ONLY. Intended for use by laboratory professionals. Not intended for human diagnostic or therapeutic purposes.
The data on this page has been compiled from LifeSpan internal sources, the National Center for Biotechnology Information (NCBI), and The Universal Protein Resource (UniProt).